# Sitagliptin

NDC: 0480-2609
Generic name: Sitagliptin
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260528

FDA application: ANDA202327

## Active ingredients

- SITAGLIPTIN PHOSPHATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-2609"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-2609
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fa5aa67-455e-4ac6-864d-268a91286432